Investorideas.com newswire, defense and security sector

Thursday, October 16, 2014

Experts and Analyst Comment on Recent Security Breaches for National Cybersecurity Month

Experts and Analyst Comment on Recent Security Breaches for National Cybersecurity Month

Scott Sacknoff of the SPADE Defense Index, Cybersecurity experts, Kiersten Todt & Roger Cressey, Gino Pereira, CEO of NXT-ID  and Scott L. Greiper, of Secure Strategy Group Share Insight

New York NY- Point Roberts WA - October 16, 2014 - Investorideas.com (www.investorideas.com), a global news source covering leading sectors including cybersecurity and biometrics, issues commentary from industry experts and analysts on recent security breaches (including Home Depot and JP Morgan) as National Cybersecurity Month drives even more awareness to the issue.

October 2014 marks the 11th Annual National Cyber Security Awareness Month, sponsored by the Department of Homeland Security, in cooperation with the National Cyber Security Alliance and the Multi-State Information Sharing and Analysis Center.

Scott Sacknoff of the SPADE Defense Index (NYSE: ^DXS) said looking at stocks in the sector, “With increasing publicity related to network attacks, an increasing number of companies are increasing their cybersecurity investments to be proactive rather than responsive to attacks. The proof of this trend can be seen as cybersecurity companies report gains in the size of their customer base as well as growth in the contracts awarded by the large, S&P100-type firms. One can expect firms such as Palo Alto Networks (PANW), FireEye (FEYE), Cyber-Ark Software (CYBR), Barracuda Networks (CUDA), and Fortinet (FTNT) to be among those that should benefit.”

Scott L. Greiper, President of Secure Strategy Group, LLC. told us, "The growing list of big-name hacking victims will support the broad secular growth being enjoyed by many companies in the cyber security sector.  Our SSG Small Cap Homeland Security Report for the first half of 2014 documents the strong performance of small caps in this sector. We anticipate growth will continue as the cyber threat and related legal concerns are taken seriously by more and more enterprises, especially small and medium companies.  To be sure, market participants need to step carefully given the presence of some inflated valuations and shifting technology requirements that can have rapid and significant impacts on certain providers.”

Cybersecurity experts, Kiersten Todt & Roger Cressey, Liberty Group Ventures commented, “National Cybersecurity Month has been dominated by news reports of successful attacks in cyberspace.  Millions of accounts, addresses, names, phone numbers, and other valuable data have been stolen.  Recent high profile cyber breaches into Home Depot and JP Morgan, in particular, have demonstrated the diverse and pervasive threats that businesses face.  What are some of the key lessons from these significant breaches? 

Corporate board members are now being held responsible and accountable for breaches.  Corporate leaders must view Cyber risk as a risk equal to credit, liquidity, and operational risks.  Assessing risk is an enterprise-wide endeavor, not merely a department, division, or company activity. The complexity of cybersecurity interdependencies is a growing challenge for companies to understand and manage.  Recent corporate breaches also reflect an increased diversification of threat actors who have significant capabilities and have exposed the difficulty in discerning whether a cybersecurity adversary is a nation-state or a sophisticated criminal organization. Companies should assume they are targets of a complete range of adversaries and intentions.

Employee behavior is a primary corporate vulnerability – spearphishing remains the primary way adversaries can infiltrate a network. Educating employees is the foundation of effective corporate cybersecurity and is often neglected.  Private organizations should not expect the government to identify threats first; information sharing between the public and private sectors is essential to maintaining security and companies must commit to continually improving methods for information sharing.

Every company can learn from past breaches and apply the best practices and lessons learned upon which industry and government have agreed.  One tool that companies have already begun to use effectively to manage cyber risk, enterprise-wide, is the application of the NIST Cybersecurity Framework.  In light of the recent court ruling requiring companies to take “reasonable efforts” on cybersecurity, application of the NIST Framework can be viewed as doing so.

No company can stop every cyber threat to its organization; companies will continue to be breached and the adversaries will continue to be more creative and opportunistic in finding vulnerabilities to exploit.  Tools and technologies that help organizations more effectively manage cyber risk will become essential for companies to prosper in the current threat environment.“

Gino Pereira, CEO of NXT-ID (NASDAQ: NXTD) said, “Companies need to approach cyber security from a holistic standpoint. Personnel, hardware and software all play a role. Authentication is a major factor. Passwords have been proven to be ineffective and biometrics are increasingly being used as a means of authentication of personnel.  Authentication should also rely on at least two factors to allow access.  Behavior of staff with access to sensitive information needs to be monitored.  Do they have outside internet access?  Can their behavior invite breaching attacks?  Companies should also look at keeping sensitive information in an encrypted format.  Here at NXT-ID, we are developing technologies that not only require dual authentication for access control but also dynamic pairing codes that change for each enquiry, making it very difficult for attackers to gain access to sensitive information.”

National Cyber Security Awareness Month is designed to engage and educate public and private sector partners through events and initiatives with the goal of raising awareness about cybersecurity and increasing the resiliency of the nation in the event of a cyber incident.


Investorideas.com has created a global cybersecurity stock directory for investors to research the sector. http://www.investorideas.com/Companies/HomelandDefense/Stock_List.asp#CyberSecurity


About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including cybersecurity.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Sign up for our free news alerts

Become an Investorideas.com Member and use our online stock directories to research stocks – including cyber, biometric and mobile payment stocks http://www.investorideas.com/membership/

Disclaimer/Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: Investorideas is compensated by NXTD five thousand per month plus 144 shares for PR, media and news publication.  .More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
800-665-0411 - Source – www.Investorideas.com






Tuesday, October 14, 2014

Aethlon Medical (OTCBB: AEMD) Announces First Treatment of an Ebola Patient

Biodefense Breaking News: Aethlon Medical (OTCBB: AEMD) Announces First Treatment of an Ebola Patient

SAN DIEGO - October 14, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus. The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital in Germany. The patient, who is also a World Health Organization (WHO) worker, contracted the virus in Sierra Leone.

The Aethlon Hemopurifier® is a first-in-class bio-filtration device that targets the rapid elimination of viruses and immunosuppressive proteins from the circulatory system of infected individuals. At present, no antiviral therapy or vaccine has proven to be effective against Ebola virus infection in humans. The largest ebola virus epidemic in history is now spreading on a global basis with more than 4,000 deaths being reported by the WHO.

"We thank the physicians in Frankfurt for allowing us the opportunity to treat this advanced-stage patient," stated Aethlon founder and CEO, Jim Joyce. "Details related to the patient's response to therapy will be disclosed once hospital officials deem it appropriate to report an update on the condition of this individual."

In the care of ebola-infected individuals, the Hemopurifier targets two unmet medical needs: the rapid elimination of circulating ebola to inhibit continued progeny virus replication and the direct targeting of shed glycoproteins that overwhelm the host immune response. The device can be deployed for use within the global infrastructure of dialysis and CRRT machines already located in hospitals and clinics.

Aethlon further disclosed that it is preparing to initiate U.S. clinical studies of Hemopurifier therapy based on the United States Food and Drug Administration's (FDA) approval of an Investigational Device Exemption (IDE) that was previously submitted by the Company. The study will contribute safety data to advance the device as a broad-spectrum countermeasure against pandemic threats, including ebola and chronic viral pathogens such as HIV and Hepatitis C (HCV).

To date, Hemopurifier therapy has been successfully administered in approximately one hundred treatment experiences in health compromised HIV and HCV infected individuals. These studies were conducted at the Apollo Hospital, Fortis Hospital, Sigma New Life Hospital, and the Medanta Medicity Institute, all located in India. In vitro validation studies that demonstrated the ability of the Hemopurifier to capture Zaire and other strains of ebola virus were conducted by researchers at the United States Army Medical Research Institute for Infectious Diseases (USAMRIID) and the United States Centers for Disease Control and Prevention (CDC).


About Aethlon Medical, Inc.
Aethlon Medical creates medical devices that target unmet therapeutic needs in infectious disease and cancer.  The company's lead product is the Aethlon Hemopurifier®, a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.  Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. For more information, please visit http://www.aethlonmedical.com/ and connect with the Company on Twitter, LinkedIn, Facebook and Google+.

Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the ESI will not be able to commercialize its future products, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy or as a broad spectrum defense against viral pathogens, including ebola, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts:
James A. Joyce 
Chairman and CEO
 
858.459.7800 x301
 
jj@aethlonmedical.com

Jim Frakes 
Chief Financial Officer
 
858.459.7800 x300
 
jfrakes@aethlonmedical.com

Visit this company: www.aethlonmedical.com

More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/

Sign up for the free investor news and stock alerts:

Disclaimer/Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: AEMD subscribes to the Investorideas newswire content publishing annual program (9700 per Year, paid quarterly) for news publishing.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Become an Investorideas.com Member and access our 14 online stock directories 24/7 –biotech, mining stocks, oil and gas stocks and more...





Investorideas.com newswire